J Am Heart Assoc July 2023 PMID 37421263

Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Population-Based Investigation.

Osung Kwon, Jun-Pyo Myong, Yunhee Lee, Yeon-Jik Choi, Jeong Eun Yi, Suk Min Seo, Sung-Won Jang, Pum Joon Kim, Jung-Min Lee

Full text PDF Download social card

Mentions

Peak: 8 in Jul 2023

across 3 sources since Jul 2023

Extended reach

49,181

potential audience

Total likes

Video views

Mentions per month

Jul 2023 – Apr 2024

Where it's discussed

X / Twitter10 posts
Facebook3 posts
YouTube1 videos

AI synopsis

What people are saying

The social discussions predominantly support the publication's findings, highlighting the clinical benefits of SGLT2 inhibitors with phrases like 'good results' and 'lower HF mortality.' Participants use precise statistics and refer to upcoming studies to demonstrate strong engagement and acknowledgment of the research's potential impact on treatment practices.

AgreementModerate agreement

Most discussions align with the positive findings of the publication, emphasizing the benefits of early SGLT2 inhibitor use after myocardial infarction in diabetic patients.

InterestHigh interest

Participants display high interest by referencing clinical results and upcoming studies like DAPA-MI, showing eagerness for advancements and applications.

EngagementHigh engagement

Several social discussions delve into specific data points, such as the 9.1% reduction in mortality and hazard ratios, indicating deep engagement with the research details.

ImpactHigh impact

The tone and content suggest a recognition of the publication's potential to influence clinical practices and future research directions, portraying it as a significant contribution.

Abstract in brief

A study investigated whether early use of SGLT2 inhibitors can protect the heart in diabetes patients who had an acute myocardial infarction.
Using data from South Korea, researchers compared patients who received SGLT2 inhibitors with those who used other glucose-lowering drugs after percutaneous coronary intervention between 2014 and 2018.
Results showed that early SGLT2 inhibitor users had a significantly lower risk of all-cause mortality, hospitalizations for heart failure, and other major cardiovascular events over a median follow-up of 2.1 years.

Read the full abstract

All mentions

SGLT2 Inhibitors Reduce Mortality Post-Myocardial Infarction in Diabetes Patients

This study investigates whether early use of SGLT2 inhibitors can protect the heart in diabetes patients who had an acute myocardial infarction. Using South Korean data, it compares outcomes between patients on SGLT2…

Social RTCL TV · Oct 15, 2023 41 views

ちろ剤師★ 検査技師のデカおっさんと師長さんに肩パン

@Toki_nd2525 · X

Apr 10, 2024 · 6 likes · 5,754 followers View post →

Rizki

@rizrasmin · X

We already have good results in T2DM population (ref. attached). DAPA-MI will focus on non-DM patients. Ref.: https://t.co/p79V36MOIC

Nov 9, 2023 · 1 like · 27 followers View post →

JAHA

@JAHA_AHA · X

Early use of SGLT2 inhibitors in DM patients treated with PCI for AMI is associated with lower HF mortality and hospitalization. #AHAJournals https://t.co/sFa3fE4G3X https://t.co/WCNNDC7AOk

Jul 18, 2023 · 5 likes · 31,353 followers View post →

近藤　健司

@29kondo · X

Jul 10, 2023 · 4 shares · 12 followers View post →

DAMIOPA

@DAMIOPA1 · X

Jul 10, 2023 · 4 shares · 68 followers View post →

Hiroyuki Sato 佐藤宏行

@foreverhero0819 · X

Jul 10, 2023 · 4 shares · 3,805 followers View post →

Gomaaaa!

@Gomaaaa5050 · X

Jul 10, 2023 · 4 shares · 1 followers View post →

宇津貴史 /Utsu, Takashi

@Office_j · X

Jul 10, 2023 · 19 likes · 4 shares · 4,912 followers View post →

Paco Tarazona

@Sabater71 · X

RT @FormigaFrancesc: Sodium‐Glucose Cotransporter‐2 Inhibitors After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Popula…

Jul 9, 2023 · 1 share · 1,218 followers View post →

Francesc Formiga

@FormigaFrancesc · X

Jul 9, 2023 · 1 share · 1,947 followers View post →